Literature DB >> 25260581

Abacopteris penangiana exerts testosterone-induced benign prostatic hyperplasia protective effect through regulating inflammatory responses, reducing oxidative stress and anti-proliferative.

Xian Yang1, Liuliu Yuan1, Chaomei Xiong2, Chunping Yin1, Jinlan Ruan3.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Abacopteris penangiana (Hook.) Ching (AP) is a member of parathelypteris glanduligera and used in folk medicine for the treatment of blood circulation and blood stasis, edema and inflammation as recorded in the ″Chinese Materia Medica″. AIM OF THE STUDY: The purpose of this study was to investigate the effects of total flavanol glycosides (TFA) from AP and its acid hydrolysate (AHT) on testosterone-induced benign prostatic hyperplasia (BPH) in rats by measuring the levels of inflammatory responses, oxidative stress and prostate cell proliferation.
MATERIALS AND METHODS: BPH was induced in rats by subcutaneous injection of testosterone after castration. Seventy rats were divided into seven groups. After oral administration of AHT and TFA (100 or 200mg/kg/d) for 4 weeks, the prostate index (PI), 5a-reductase (5α-R) and dihydrotestosterone (DHT) were determined. Then the activities of superoxide dismutase (SOD), glutathione peroxidase (GPx) and catalase (CAT) were determined. In addition, the relative inflammatory factors, cyclooxygenase-2 (COX-2), tumor necrosis factor-α (TNF-α), interleukin 1β (IL-1β), interleukin 6 (IL-6), interleukin 8 (IL-8) and interleukin 17 (IL-17) were measured. Finally, the prostatic expression of nuclear transcription factor-κB (NF-κB) and phosphoinositide3-kinase (PI3K)/Akt were determined by immunohistochemistry. The prostatic expression of Bcl-2 was determined by western blot analysis.
RESULTS: The results showed that AHT and TFA decreased serum DHT and 5α-R activities compared with model group, as well as the PI and histopathological examination findings. In addition, oral treatment of AHT and TFA can significantly increase the activities of SOD, GPx and CAT while the level of MDA was significantly decreased compared with the model group. Moreover, AHT and TFA remarkably decreased the levels of inflammatory cytokines in prostatic tissue. Further investigation demonstrated that AHT and TFA treatment down-regulated the protein expressions of p-Akt, NF-κB and Bcl-2.
CONCLUSIONS: These results suggest that AHT and TFA have anti-BPH properties via anti-inflammatory, antioxidant and anti-proliferative effects. Hence, AP represents a potential herb for the treatment of BPH.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Abacopteris penangiana; Apoptosis; Benign prostatic hyperplasia; Inflammatory responses; Oxidative stress

Mesh:

Substances:

Year:  2014        PMID: 25260581     DOI: 10.1016/j.jep.2014.09.025

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  16 in total

1.  Bee venom suppresses testosterone-induced benign prostatic hyperplasia by regulating the inflammatory response and apoptosis.

Authors:  Kyung-Sook Chung; Hyo-Jin An; Se-Yun Cheon; Ki-Rok Kwon; Kwang-Ho Lee
Journal:  Exp Biol Med (Maywood)       Date:  2015-06-17

2.  Modeling of Benign Prostatic Hyperplasia in Rats with a High Dose of Testosterone.

Authors:  I V Sorokina; N A Zhukova; Yu V Meshkova; D S Baev; T G Tolstikova; M A Bakarev; E L Lushnikova
Journal:  Bull Exp Biol Med       Date:  2022-10-10       Impact factor: 0.737

3.  Inhibitory effects of Hydrocotyle ramiflora on testosterone-induced benign prostatic hyperplasia in rats.

Authors:  Suyoung Park; Youn-Hwan Hwang; Eun-Bok Baek; Eun-Ju Hong; Young-Suk Won; Hyo-Jung Kwun
Journal:  Int Urol Nephrol       Date:  2022-09-15       Impact factor: 2.266

4.  Origanum majorana L. Extract Attenuated Benign Prostatic Hyperplasia in Rat Model: Effect on Oxidative Stress, Apoptosis, and Proliferation.

Authors:  Dalia Mahmoud Abdelmonem Elsherbini; Hailah M Almohaimeed; Mohamed El-Sherbiny; Zuhair M Mohammedsaleh; Nehal M Elsherbiny; Sami A Gabr; Hasnaa Ali Ebrahim
Journal:  Antioxidants (Basel)       Date:  2022-06-11

5.  Immunomodulatory effect of diallyl sulfide on experimentally-induced benign prostate hyperplasia via the suppression of CD4+T/IL-17 and TGF-β1/ERK pathways.

Authors:  Eman M Elbaz; Hebat Allah A Amin; Ahmed S Kamel; Sherehan M Ibrahim; Hebatullah S Helmy
Journal:  Inflammopharmacology       Date:  2020-08-12       Impact factor: 4.473

6.  Quantification of Arachidonic Acid and Its Metabolites in Rat Tissues by UHPLC-MS/MS: Application for the Identification of Potential Biomarkers of Benign Prostatic Hyperplasia.

Authors:  Qiaoxia Bian; Weihui Wang; Nannan Wang; Yan Peng; Wen Ma; Ronghua Dai
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

7.  Inhibitory effects of Ponciri Fructus on testosterone-induced benign prostatic hyperplasia in rats.

Authors:  Woo-Young Jeon; Ohn Soon Kim; Chang-Seob Seo; Seong Eun Jin; Jung-Ae Kim; Hyeun-Kyoo Shin; Yong-Ung Kim; Mee-Young Lee
Journal:  BMC Complement Altern Med       Date:  2017-08-03       Impact factor: 3.659

8.  Effect of Silodosin, an Alpha1A-Adrenoceptor Antagonist, on Ventral Prostatic Hyperplasia in the Spontaneously Hypertensive Rat.

Authors:  Shogo Shimizu; Takahiro Shimizu; Panagiota Tsounapi; Youichirou Higashi; Darryl T Martin; Kumiko Nakamura; Masashi Honda; Keiji Inoue; Motoaki Saito
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

9.  Inhibitory Effect of Yongdamsagan-Tang Water Extract, a Traditional Herbal Formula, on Testosterone-Induced Benign Prostatic Hyperplasia in Rats.

Authors:  Eunsook Park; Mee-Young Lee; Woo-Young Jeon; Nari Lee; Chang-Seob Seo; Hyeun-Kyoo Shin
Journal:  Evid Based Complement Alternat Med       Date:  2016-07-18       Impact factor: 2.629

10.  Metformin Attenuates Testosterone-Induced Prostatic Hyperplasia in Rats: A Pharmacological Perspective.

Authors:  Hala H Mosli; Ahmed Esmat; Reem T Atawia; Sherif M Shoieb; Hisham A Mosli; Ashraf B Abdel-Naim
Journal:  Sci Rep       Date:  2015-10-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.